These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27699722)

  • 1. Imaging as an Outcome Measure in Multiple Sclerosis.
    Ontaneda D; Fox RJ
    Neurotherapeutics; 2017 Jan; 14(1):24-34. PubMed ID: 27699722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of multiple sclerosis: role in neurotherapeutics.
    Bakshi R; Minagar A; Jaisani Z; Wolinsky JS
    NeuroRx; 2005 Apr; 2(2):277-303. PubMed ID: 15897951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging outcome measures for progressive multiple sclerosis trials.
    Moccia M; de Stefano N; Barkhof F
    Mult Scler; 2017 Oct; 23(12):1614-1626. PubMed ID: 29041865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.
    Sastre-Garriga J; Pareto D; Battaglini M; Rocca MA; Ciccarelli O; Enzinger C; Wuerfel J; Sormani MP; Barkhof F; Yousry TA; De Stefano N; Tintoré M; Filippi M; Gasperini C; Kappos L; Río J; Frederiksen J; Palace J; Vrenken H; Montalban X; Rovira À;
    Nat Rev Neurol; 2020 Mar; 16(3):171-182. PubMed ID: 32094485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallmarks of spinal cord pathology in multiple sclerosis.
    Kreiter D; Postma AA; Hupperts R; Gerlach O
    J Neurol Sci; 2024 Jan; 456():122846. PubMed ID: 38142540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis.
    Inglese M; Fleysher L; Oesingmann N; Petracca M
    Expert Rev Neurother; 2018 Mar; 18(3):221-230. PubMed ID: 29369733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
    Granziera C; Wuerfel J; Barkhof F; Calabrese M; De Stefano N; Enzinger C; Evangelou N; Filippi M; Geurts JJG; Reich DS; Rocca MA; Ropele S; Rovira À; Sati P; Toosy AT; Vrenken H; Gandini Wheeler-Kingshott CAM; Kappos L;
    Brain; 2021 Jun; 144(5):1296-1311. PubMed ID: 33970206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging in Multiple Sclerosis.
    Hemond CC; Bakshi R
    Cold Spring Harb Perspect Med; 2018 May; 8(5):. PubMed ID: 29358319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.
    Oh J; Ontaneda D; Azevedo C; Klawiter EC; Absinta M; Arnold DL; Bakshi R; Calabresi PA; Crainiceanu C; Dewey B; Freeman L; Gauthier S; Henry R; Inglese M; Kolind S; Li DKB; Mainero C; Menon RS; Nair G; Narayanan S; Nelson F; Pelletier D; Rauscher A; Rooney W; Sati P; Schwartz D; Shinohara RT; Tagge I; Traboulsee A; Wang Y; Yoo Y; Yousry T; Zhang Y; Robert Z; Sicotte NL; Reich DS;
    Neurology; 2019 Mar; 92(11):519-533. PubMed ID: 30787160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR myelin imaging in multiple sclerosis: A scoping review.
    Khormi I; Al-Iedani O; Alshehri A; Ramadan S; Lechner-Scott J
    J Neurol Sci; 2023 Dec; 455():122807. PubMed ID: 38035651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging outcomes for trials of remyelination in multiple sclerosis.
    Mallik S; Samson RS; Wheeler-Kingshott CA; Miller DH
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1396-404. PubMed ID: 24769473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Sclerosis Part 2: Advanced Imaging and Emerging Techniques.
    Mishra S; Bapuraj J; Srinivasan A
    Magn Reson Imaging Clin N Am; 2024 May; 32(2):221-231. PubMed ID: 38555138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases.
    Traboulsee A; Li DKB
    Neuroimaging Clin N Am; 2024 Aug; 34(3):317-334. PubMed ID: 38942519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice.
    Bruschi N; Boffa G; Inglese M
    Eur Radiol Exp; 2020 Oct; 4(1):59. PubMed ID: 33089380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honing in on magnetic resonance imaging predictors of multiple sclerosis pathology.
    Schmierer K
    Brain Pathol; 2023 Nov; 33(6):e13209. PubMed ID: 37646614
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice.
    Rocca MA; Margoni M; Battaglini M; Eshaghi A; Iliff J; Pagani E; Preziosa P; Storelli L; Taoka T; Valsasina P; Filippi M
    Radiology; 2023 Jun; 307(5):e221512. PubMed ID: 37278626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New imaging techniques in the diagnosis of multiple sclerosis.
    Fu Y; Talavage TM; Cheng JX
    Expert Opin Med Diagn; 2008 Sep; 2(9):1055-65. PubMed ID: 19337386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a standard MRI protocol for multiple sclerosis across the UK.
    Schmierer K; Campion T; Sinclair A; van Hecke W; Matthews PM; Wattjes MP
    Br J Radiol; 2019 Sep; 92(1101):20180926. PubMed ID: 30994035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the heterogeneity of MS lesions using positron emission tomography: a reappraisal of their contribution to disability.
    Stankoff B; Poirion E; Tonietto M; Bodini B
    Brain Pathol; 2018 Sep; 28(5):723-734. PubMed ID: 30020560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Monitoring in Multiple Sclerosis - Efficacy and Safety.
    Mahmoudi N; Wattjes MP
    Neuroimaging Clin N Am; 2024 Aug; 34(3):439-452. PubMed ID: 38942526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.